Literature DB >> 34377925

Intrastent haematoma after treatment with a drug-eluting balloon for in-stent restenosis: a case report.

Xu-Lin Hong1,2, Guo-Sheng Fu1,2, Zhan-Lu Li1, Wen-Bin Zhang1,2.   

Abstract

BACKGROUND: Intrastent haematoma after dilatation of in-stent restenosis (ISR) is rarely reported and the optimal treatment for this condition remains unclear. CASE
SUMMARY: We present the case of an 87-year-old man with in-stent subtotal occlusion of left circumflex. He experienced chest pain after drug-eluting balloon was released in the stent. Intravascular ultrasound revealed intrastent haematoma, which was not relieved with a cutting balloon but completely sealed by an Endeavor Resolute stent. DISCUSSION: Intrastent haematoma after dilatation of ISR is rare. Reimplantation of stent seems the best method to solve this problem. Intravascular ultrasound imaging may provide insight into the cause of ISR and guide the treatment.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  In-stent restenosis; Intrastent haematoma; Intravascular ultrasound • Case report

Year:  2021        PMID: 34377925      PMCID: PMC8350352          DOI: 10.1093/ehjcr/ytab295

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Balloon angioplasty of in-stent restenosis (ISR) is not completely without risk. Intrastent haematoma, which is rare after dilatation of in-stent lesions, may not be relieved by a cutting balloon but can be sealed by implanting a new stent. Intravascular ultrasound imaging can provide insight into the cause of ISR and guide the treatment.

Introduction

Intimal tears or dissections following percutaneous transluminal coronary angioplasty (PTCA) in de novo coronary lesions are very common. Coronary stents are occasionally used once a large dissection has been caused. However, for in-stent restenosis (ISR), intimal dissection, or intrastent haematoma after dilatation is rarely reported and the optimal treatment for this condition remains unclear.

Case presentation

An 87-year-old man was admitted to our hospital for recurrent chest distress. His past medical history revealed hypertension, diabetes mellitus, coronary artery disease with percutaneous coronary intervention (PCI) to right coronary artery (RCA) in 2013 and to left circumflex (LCX) in 2015. The patient was taking clopidogrel, atorvastatin, irbesartan, and antidiabetics drugs regularly. During the outpatient clinic follow-up, he developed progressive dyspnoea (New York Heart Association III) within 1 month. Finally, he was sent to our department with recurrent shortness of breath and angina. The physical cardiovascular examination revealed a diastolic decrescendo murmur heard best at the left sternal border and clinical signs of heart failure. Electrocardiogram showed inverted T wave in V3–6 and Q wave in II, III, aVF lead. Troponin was 0.430 ng/mL (reference value: <0.110 ng/mL), and N-terminal pro-brain natriuretic peptide was 6981 pg/mL (reference value: <1800 pg/mL). Transthoracic echocardiography showed moderate aortic regurgitation and the left ventricular ejection fraction was 36%. Coronary angiography (CAG) indicated mild ISR of proximal RCA and subtotal occlusion of LCX (). Therefore, PCI was attempted. The lesion was prepared with 2.0/20 mm compliant and 2.75/10 mm non-compliant balloon, following which a 2.75/30 mm drug-eluting balloon (DEB) (8 atm) (Swide, Shanghai, China) was released in the stent (). A few minutes later, the patient experienced chest pain. Coronary angiography showed severe in-stent narrowing and intravascular ultrasound (IVUS) revealed intrastent haematoma (), which was not relieved with a 2.75/10 mm cutting balloon (8 atm) (). Thus, the lesion was treated with implantation of an Endeavor Resolute 2.75/30 mm stent. Final CAG and IVUS confirmed complete sealing of the haematoma ().
Figure 1

(A) Initial coronary angiography indicated that left circumflex was subtotal occluded (white arrowhead). (B) Coronary angiography after dilatation with 2.0/20 mm compliant and 2.75/10 mm non-compliant balloon. (C) Drug-eluting balloon was released in the stent. (D) Final coronary angiography after drug-eluting balloon was released.

(A) Initial coronary angiography indicated that left circumflex was subtotal occluded (white arrowhead). (B) Coronary angiography after dilatation with 2.0/20 mm compliant and 2.75/10 mm non-compliant balloon. (C) Drug-eluting balloon was released in the stent. (D) Final coronary angiography after drug-eluting balloon was released. (A) Coronary angiography and the corresponding intravascular ultrasound revealed intrastent haematoma (red dashed area in figure a). (B) Haematoma was not relieved after dilatation with a cutting balloon (intimal flap was shown in figure b1, white arrowhead; the following intrastent haematoma was marked with a dotted red line in figure b2). (C) Final results confirmed complete sealing of the haematoma after drug-eluting stent implantation.

Discussion

In-stent restenosis, which is angiographically defined as >50% reduction in luminal area within the stent or in the adjacent native vessel (5 mm of the proximal or distal stent edge), remains the most frequent cause of stent failure and the most common indication for target lesion revascularization. The two most effective treatment of ISR are DEB-angioplasty or repeat stenting with drug-eluting stent., However, balloon angioplasty of ISR is not completely without risk. Complications in terms of significant residual dissection or intrastent haematoma are rare but may occur. The underlying mechanisms of intrastent haematoma remain unclear. Possible explanations are as follows: (i) rupture of the new capillaries in the new plaque in the stent; (ii) blood flows into the plaque after fibrous cap rupture. Reimplantation of stent seems inevitable under the circumstance. Our case has limitations, intracoronary imaging of ISR with IVUS should be recommended before revascularization to detect the mechanisms underlying ISR especially when the patient’s original lesion and the initial procedure could not be reviewed. Nonetheless, IVUS imaging provide insight into the failure of treatment with DEB and guide the further revascularization successfully.

Lead author biography

Wen-Bin Zhang is a medical doctor at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine. He has rich experience in interventional treatment of complex coronary heart disease. He once studied under Professor Gary Mintz in Columbia University and he is a member of American College of Cardiology and the fellow of SCAI. He has published nearly 30 articles in international high-quality journals as the first author/corresponding author. He is the young editor of ‘Cardiovascular Innovations and Applications’ and ‘Chinese Journal of Interventional Cardiology’.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data. Consent: The authors confirm that written consent for submission and publication of this case report including images and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: None declared. Funding: This study was funded by the National Natural Science Foundation of China (82070408) and Medical and Health science program of Zhejiang Province (2021RC014 and 2019RC185). Click here for additional data file.
Day/monthEvent
1 monthProgressive dyspnoea (New York Heart Association III).
Day 1Admission for shortness of breath, angina with heart failure.
Day 2Electrocardiogram showed inverted T wave in V3–6 and Q wave in II, III, aVF lead. Troponin was 0.430 ng/mL, and N-terminal pro-brain natriuretic peptide was 6981 pg/mL. Transthoracic echocardiography showed moderate aortic regurgitation and the left ventricular ejection fraction was 36%.
Day 5Coronary angiography indicated subtotal occlusion of left circumflex. A 2.75/30 mm drug-eluting balloon was released in the stent after successful pre-dilatation. A few minutes later, the patient experienced chest pain. Intravascular ultrasound revealed intrastent haematoma, which was not relieved with a cutting balloon but completely sealed by a drug-eluting stent.
Day 8Patient discharged home without complication.
  7 in total

Review 1.  Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.

Authors:  George C M Siontis; Giulio G Stefanini; Dimitris Mavridis; Konstantinos C Siontis; Fernando Alfonso; María J Pérez-Vizcayno; Robert A Byrne; Adnan Kastrati; Bernhard Meier; Georgia Salanti; Peter Jüni; Stephan Windecker
Journal:  Lancet       Date:  2015-08-15       Impact factor: 79.321

2.  Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis.

Authors:  R Mehran; G S Mintz; J J Popma; A D Pichard; L F Satler; K M Kent; J Griffin; M B Leon
Journal:  Am J Cardiol       Date:  1996-09-15       Impact factor: 2.778

3.  Complications of cardiac catheterization versus coronary angiography.

Authors:  V L Roger; G S Reeder; A J Tajik
Journal:  Mayo Clin Proc       Date:  1996-07       Impact factor: 7.616

4.  2018 ESC/EACTS Guidelines on myocardial revascularization.

Authors:  Franz-Josef Neumann; Miguel Sousa-Uva; Anders Ahlsson; Fernando Alfonso; Adrian P Banning; Umberto Benedetto; Robert A Byrne; Jean-Philippe Collet; Volkmar Falk; Stuart J Head; Peter Jüni; Adnan Kastrati; Akos Koller; Steen D Kristensen; Josef Niebauer; Dimitrios J Richter; Petar M Seferović; Dirk Sibbing; Giulio G Stefanini; Stephan Windecker; Rashmi Yadav; Michael O Zembala
Journal:  EuroIntervention       Date:  2019-02-20       Impact factor: 6.534

5.  Intrastent Hematoma After Pre-Dilatation for 17-Month Restenosis of Polytetrafluoroethylene-Covered Stent: Insights From Intravascular Imaging.

Authors:  Satoru Mitomo; Francesco Giannini; Luciano Candilio; Antonio Mangieri; Daisuke Hachinohe; Azeem Latib; Antonio Colombo
Journal:  JACC Cardiovasc Interv       Date:  2017-12-11       Impact factor: 11.195

Review 6.  Contemporary Management of Stent Failure: Part One.

Authors:  Nikhil Pal; Jehangir Din; Peter O'Kane
Journal:  Interv Cardiol       Date:  2019-02

Review 7.  Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.

Authors:  Daniele Giacoppo; Giuseppe Gargiulo; Patrizia Aruta; Piera Capranzano; Corrado Tamburino; Davide Capodanno
Journal:  BMJ       Date:  2015-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.